Bilateral transpedicular vertebral augmentation with inflatable bone tamp and PMMA cement for painful osteoporotic or pathological compression fractures | intermediate
Surgical Imaging
The trap: A medial pedicle breach during cannula placement allows the trocar to enter the spinal canal and injure the thecal sac or cord.
The fix: Use true AP and lateral fluoroscopy throughout. On AP view the medial pedicle wall must remain lateral to the medial border of the pedicle shadow until the cannula has passed the posterior wall. Any medial deviation requires immediate redirection.
Location: The posterior vertebral wall is the critical barrier; breach allows cement to enter the canal and compress neural elements.
Risk: Posterior wall fracture lines or tumour erosion are common in pathological fractures. Continuous lateral fluoroscopy during cement injection is mandatory; any posterior extravasation requires immediate stoppage.
Location: Basivertebral veins and segmental veins communicate directly with the vertebral body; cement can travel to the vena cava and cause pulmonary embolism.
Risk: High-pressure injection or low-viscosity cement increases venous filling. Use higher-viscosity PMMA after cavity creation and inject slowly under real-time imaging; stop if any venous opacification appears.
Deformity pattern: Over-aggressive balloon inflation in severely osteoporotic bone can fracture the superior or inferior endplate rather than elevate it.
Implication: This creates a direct pathway for cement leakage into the disc space and may worsen kyphosis. Inflate the tamp gradually in 0.5 mL increments while monitoring endplate position on lateral fluoroscopy.
Why different: Kyphoplasty alters load transfer through the stiffened augmented vertebra; the adjacent levels experience increased stress.
Implications: New fractures occur in 10-20 percent of patients within 1 year. Optimise osteoporosis pharmacotherapy (bisphosphonates, denosumab or anabolic agents) and consider prophylactic augmentation only in highly selected cases with multiple levels at risk.
Kanavel equivalent signs: Sudden desaturation, hypotension or chest pain during or immediately after cement injection.
Management: Immediate cessation of injection, supportive ventilation, urgent CT pulmonary angiogram. Most small emboli are asymptomatic but larger fragments require endovascular retrieval or anticoagulation decisions in consultation with interventional radiology and respiratory teams.
K.Y.P.H.OKYPHOPLASTY — Patient Selection and Safety
T.A.M.PTAMP — Operative Sequence
Surgical Indications
Absolute Indications
- Painful vertebral compression fracture with mechanical axial pain correlating to the fractured level
- Subacute fracture (typically less than 3 months) demonstrating bone marrow oedema on MRI STIR or T2 fat-suppressed sequences
- Failure of conservative management including analgesia, bracing and physiotherapy for at least 4-6 weeks
- Pathological fractures due to myeloma, lymphoma or metastatic disease with mechanical pain and limited life expectancy where stabilisation improves quality of life
Relative Indications
- Progressive kyphosis with sagittal imbalance and secondary pain
- Multiple contiguous fractures where staged augmentation may prevent further collapse
- Patients with severe osteoporosis in whom prolonged bracing is poorly tolerated
Contraindications
Absolute:
- Active spinal infection or osteomyelitis at the target level
- Neurological deficit attributable to the fracture (cord or cauda equina compression requiring decompression)
- Burst fracture with significant retropulsion and canal compromise
- Coagulopathy that cannot be corrected
Relative:
- Chronic fracture without oedema on MRI (pain relief rates drop below 50 percent)
- Greater than 50 percent vertebral height loss with severe endplate fragmentation (technical difficulty)
- Allergy to PMMA cement components
Evidence Base
Balloon kyphoplasty and vertebroplasty both provide rapid pain relief in appropriately selected patients. The key distinction is that kyphoplasty creates a cavity with the inflatable bone tamp before cement injection. This permits use of higher-viscosity cement at lower pressure and aims for partial height restoration and kyphosis correction.
Landmark trials (FREE, VERTOS II, KAST) demonstrated significant pain and function improvement versus conservative care at 1 month, with benefits persisting to 12-24 months in many patients. Direct comparisons with vertebroplasty show similar pain scores but modestly greater height restoration and kyphosis correction with kyphoplasty, at the cost of slightly longer operative time. Cement leakage rates are lower with kyphoplasty (approximately 5-10 percent versus 20-30 percent in vertebroplasty) but are not eliminated. Adjacent-level fracture rates are comparable between the two techniques.
Kyphoplasty versus Vertebroplasty — Evidence Summary
Key Evidence
Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures
Percutaneous vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (VERTOS II)
Kyphoplasty versus vertebroplasty for the treatment of painful osteoporotic vertebral compression fractures
Safety and efficacy of balloon kyphoplasty at 2 years: a meta-analysis
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“A 72-year-old woman with known osteoporosis presents with 8 weeks of severe mechanical mid-thoracic pain after a minor fall. MRI shows a T8 compression fracture with bone marrow oedema. She has failed bracing and analgesia. How do you decide whether balloon kyphoplasty is appropriate and what are the key technical points?”
“During balloon inflation at L1 you notice on lateral fluoroscopy that the superior endplate is fracturing rather than elevating. What do you do?”
“You are performing kyphoplasty at T12 in a patient with myeloma. During cement injection on the right side you see immediate posterior extravasation on lateral fluoroscopy. The patient is under general anaesthesia. What is your response?”